pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-449b |
Genomic Coordinates | chr5: 55170646 - 55170742 |
Description | Homo sapiens miR-449b stem-loop |
Comment | None |
RNA Secondary Structure | ![]() |
Associated Diseases | ![]() |
Mature miRNA Information | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-449b-5p | ||||||||||||||||||
Sequence | 16| AGGCAGUGUAUUGUUAGCUGGC |37 | ||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||
Experiments | Microarray | DRVs in miRNA |
|
||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | PAPLN | ||||||||||||||||||||
Synonyms | - | ||||||||||||||||||||
Description | papilin, proteoglycan like sulfated glycoprotein | ||||||||||||||||||||
Transcript | NM_173462 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on PAPLN | |||||||||||||||||||||
3'UTR of PAPLN (miRNA target sites are highlighted) |
>PAPLN|NM_173462|3'UTR 1 GGATGAAGGCTAGTTCCAGCCCCAGTCCAAAATAGTTCATAGGGCTAGGGAGAAAGGAAGATGGACTCTTGGCTTCCTCT 81 CTCTGGCTGGCAAAGGGAGTTATCTTCTGGAATACATTAGCTCTTTCAAAAACCCACCCAGTGTTTAGCCTCAACGGCAG 161 CCAGTTACCAGCTTCTCTCTGTAGCCTTCAGCAGTGTTTGCATCTCTGACATAACCACAGGCTGCTGTTTTCAAGAAGAG 241 CAATCTGTTTGGATAAGAAAAACCTTTACTTTACAGCTTCCCTTTATAATTTGTTACACAGGAATAGTTAAATGCATTTG 321 TTTGTTTGTTTTTTGAGACAGAGTTTCACTCTTGTTGCCCAGGCTGGAGGGCAATGGCGCGATCTCAGCTCACTGCAACC 401 TCCGTCTCCTGGGTTCTTGATTCTCCTGTGTCAGCCTTCTGAGTAGCTAGGATTACAGATGCCTATCACCATGCCTGGGT 481 AATTTTTGTATTTTTAGTTGAGATGGGGTTTCACCATGTTGGCCAGGCTGGTCTCGAACTTCTGACCTCAGATGATCTGC 561 CCGCCTCAGCCTCCCAAAGTGCTGGGATTACAGGCATGAGCCACCACGCCCAGCCATCAATGCATTTTTTTTATTTTTTT 641 TTTGAGACAGAGTTTCGCACTTCTTGCCCAGGCTGGAGTACAATGGTGCGATCTTGGCTCACTGCAACCTCCACCTCCTG 721 GGTTCAAGCGCTTCTCCAGCCTCAGCCTCCTGAGTAGCTGGGATTACAGGTATGTGCCACCATGCCTGGCTAATTTTGTA 801 TTTTTAGTAGAGACGGGGTTTCTCCATGTTGGTCAGACTGGTCTTGAACTCCCGACCTCAGGTAATCCGCCCGCCTCGGC 881 CTCCCAAAATGCTGGGATTAGAGGTGTGAGCCACTGTGCCCAGCCCATCAATGTGTTTTAAAGCTAGCTGTCAGGGTTCC 961 ACTTAATTTAAAGCTGGGCAGGGAGATGTGTAATGATTTCAAAGTTAACACCTGTTTGTTTTCTAAAGGGCATGCCAAGT 1041 CCTGCTGTATCAGGGAAGTATTCTGTGCTAAAATCAGCGATGGTTCATTGCTCTAGTCTCTCTCACCCTTCTAGGCAGTG 1121 CATCAGTCAGCTCTAAATCTGGTGCAGAGGGTTAACAGCATAACCCTTGTTGGCAAAATGGAATAGATGTTAAGACCTCA 1201 AATAGGGATTTGGGATGAAACAGCTGCAGTTAGCACTGTTATCTGAGCATGAAAGAACTGGAAACGCTCCTTACGTCGAG 1281 ATGTTGGACCTTGAAGCCCTCCTGAGGCCAACATGCAAATCTGGCTGTGACGGTTCATCTGACACCTGTGTAAAGCTGAC 1361 CAGCCTGCTCTGTACAGTGACAATGAGGAGCCCCTCTCTTCCTTAAGTAGGAATCTGTGAAGCAAAATGTTTGCTGCCAA 1441 AGACAAATCAGACTGTCAGTCATTAAAAACAGCATTAGCAGGATGAGGATAGCAATGGGGAAGGGTTGTGGGCAATGCAG 1521 TAACAGGGAAATGGCTTCAGAAATGGTTTGAGTTGGAAGACAACATTCTTCATCTCTCAGGACTTCTAATTCCTTGATGC 1601 TAAAAGAAGAGGCATGGATTCTATGAGCTTCCAAGTCCCTTTCCACTTTAACCTTCTACAAATCTTTCAGAGGACTGCCT 1681 AGTAGCAAAGGTTATTCCTGGACACAGGAAAGACGGGCATTACAGGGACCAAAGCTCTGAAAGGTGACTTTTATTACCAA 1761 CACACTGGCTGGAAAAGGGACAAACCACATCACGGGTGAGTGATACTTCTCAGTCTTCTCTACTCATTCAACAAAGGAAA 1841 TGTGGGCTGGGGCAGAGGTCTTTTTTCATTTAATACTGGAAAAATATTGAAGAGCATCCATGTTCACTTATGGCTGGTTT 1921 TGCTATAGAAATTGGAAAATAAAGGCCACTTTTTTGAAATCCCCAGTTTAATTAAAAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM545213. RNA binding protein: AGO2. Condition:Control
... - Hafner M; Landthaler M; Burger L; Khorshid et al., 2010, Cell. |
Article |
- Hafner M; Landthaler M; Burger L; Khorshid et al. - Cell, 2010
RNA transcripts are subject to posttranscriptional gene regulation involving hundreds of RNA-binding proteins (RBPs) and microRNA-containing ribonucleoprotein complexes (miRNPs) expressed in a cell-type dependent fashion. We developed a cell-based crosslinking approach to determine at high resolution and transcriptome-wide the binding sites of cellular RBPs and miRNPs. The crosslinked sites are revealed by thymidine to cytidine transitions in the cDNAs prepared from immunopurified RNPs of 4-thiouridine-treated cells. We determined the binding sites and regulatory consequences for several intensely studied RBPs and miRNPs, including PUM2, QKI, IGF2BP1-3, AGO/EIF2C1-4 and TNRC6A-C. Our study revealed that these factors bind thousands of sites containing defined sequence motifs and have distinct preferences for exonic versus intronic or coding versus untranslated transcript regions. The precise mapping of binding sites across the transcriptome will be critical to the interpretation of the rapidly emerging data on genetic variation between individuals and how these variations contribute to complex genetic diseases.
LinkOut: [PMID: 20371350]
|
CLIP-seq Support 1 for dataset GSM545213 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / Control |
Location of target site | ENST00000381166.3 | 3UTR | AGCCCAGGUUGAGAAGC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
109 hsa-miR-449b-5p Target Genes:
Functional analysis:
ID![]() |
Target | Description | Validation methods |
![]() |
![]() |
|||||||
Strong evidence | Less strong evidence | |||||||||||
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|||||
MIRT006349 | SIRT1 | sirtuin 1 | ![]() |
![]() |
2 | 1 | ||||||
MIRT006350 | CCNE2 | cyclin E2 | ![]() |
![]() |
![]() |
![]() |
4 | 3 | ||||
MIRT006351 | MET | MET proto-oncogene, receptor tyrosine kinase | ![]() |
![]() |
2 | 1 | ||||||
MIRT006352 | GMNN | geminin, DNA replication inhibitor | ![]() |
![]() |
2 | 1 | ||||||
MIRT006353 | HDAC1 | histone deacetylase 1 | ![]() |
![]() |
2 | 1 | ||||||
MIRT016137 | CDK4 | cyclin dependent kinase 4 | ![]() |
1 | 1 | |||||||
MIRT016138 | CDC25A | cell division cycle 25A | ![]() |
![]() |
2 | 1 | ||||||
MIRT016139 | CDK6 | cyclin dependent kinase 6 | ![]() |
![]() |
![]() |
![]() |
4 | 3 | ||||
MIRT057740 | ZDHHC16 | zinc finger DHHC-type containing 16 | ![]() |
![]() |
2 | 2 | ||||||
MIRT078636 | FAM104A | family with sequence similarity 104 member A | ![]() |
![]() |
2 | 2 | ||||||
MIRT100407 | HSPA1B | heat shock protein family A (Hsp70) member 1B | ![]() |
![]() |
2 | 2 | ||||||
MIRT115552 | MAZ | MYC associated zinc finger protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT130146 | TXNIP | thioredoxin interacting protein | ![]() |
![]() |
2 | 4 | ||||||
MIRT142254 | DCTN5 | dynactin subunit 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT143724 | CCL22 | C-C motif chemokine ligand 22 | ![]() |
![]() |
2 | 2 | ||||||
MIRT168101 | E2F3 | E2F transcription factor 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT169809 | GIGYF1 | GRB10 interacting GYF protein 1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT183694 | MDM4 | MDM4, p53 regulator | ![]() |
![]() |
2 | 2 | ||||||
MIRT198922 | SMAD4 | SMAD family member 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT202950 | TSN | translin | ![]() |
![]() |
2 | 4 | ||||||
MIRT221565 | CBX3 | chromobox 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT253418 | EVI5L | ecotropic viral integration site 5 like | ![]() |
![]() |
2 | 2 | ||||||
MIRT294759 | ZNF551 | zinc finger protein 551 | ![]() |
![]() |
2 | 4 | ||||||
MIRT307053 | TGFBR2 | transforming growth factor beta receptor 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT331273 | TM9SF3 | transmembrane 9 superfamily member 3 | ![]() |
![]() |
2 | 6 | ||||||
MIRT372293 | UBXN2B | UBX domain protein 2B | ![]() |
![]() |
2 | 2 | ||||||
MIRT374317 | MBD6 | methyl-CpG binding domain protein 6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT445817 | DNAAF3 | dynein axonemal assembly factor 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT447158 | MFSD8 | major facilitator superfamily domain containing 8 | ![]() |
![]() |
2 | 2 | ||||||
MIRT447823 | CTIF | cap binding complex dependent translation initiation factor | ![]() |
![]() |
2 | 2 | ||||||
MIRT448798 | GMFB | glia maturation factor beta | ![]() |
![]() |
2 | 2 | ||||||
MIRT451580 | HIRIP3 | HIRA interacting protein 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT452679 | GPR156 | G protein-coupled receptor 156 | ![]() |
![]() |
2 | 2 | ||||||
MIRT453158 | CNOT4 | CCR4-NOT transcription complex subunit 4 | ![]() |
![]() |
2 | 6 | ||||||
MIRT453634 | SLC4A2 | solute carrier family 4 member 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT455384 | PLA2G2D | phospholipase A2 group IID | ![]() |
![]() |
2 | 2 | ||||||
MIRT456958 | SPAM1 | sperm adhesion molecule 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT462739 | EFNB1 | ephrin B1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT464321 | UST | uronyl 2-sulfotransferase | ![]() |
![]() |
2 | 2 | ||||||
MIRT465641 | TNRC18P2 | trinucleotide repeat containing 18 pseudogene 2 | ![]() |
![]() |
2 | 10 | ||||||
MIRT466748 | SYNGR2 | synaptogyrin 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT468345 | SF3B3 | splicing factor 3b subunit 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT469324 | RGP1 | RGP1 homolog, RAB6A GEF complex partner 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT474361 | KMT2D | lysine methyltransferase 2D | ![]() |
![]() |
2 | 2 | ||||||
MIRT475316 | IFNLR1 | interferon lambda receptor 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT477759 | EDEM3 | ER degradation enhancing alpha-mannosidase like protein 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT477824 | DYRK3 | dual specificity tyrosine phosphorylation regulated kinase 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT478265 | DDX19B | DEAD-box helicase 19B | ![]() |
![]() |
2 | 2 | ||||||
MIRT481042 | BAZ2A | bromodomain adjacent to zinc finger domain 2A | ![]() |
![]() |
2 | 2 | ||||||
MIRT481289 | ATXN1L | ataxin 1 like | ![]() |
![]() |
2 | 2 | ||||||
MIRT482730 | COPZ1 | coatomer protein complex subunit zeta 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT488780 | CYTH3 | cytohesin 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT489578 | SSBP2 | single stranded DNA binding protein 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT489659 | SHMT1 | serine hydroxymethyltransferase 1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT490527 | KIAA1715 | lunapark, ER junction formation factor | ![]() |
![]() |
2 | 2 | ||||||
MIRT492949 | NEUROD2 | neuronal differentiation 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT493154 | MKNK2 | MAP kinase interacting serine/threonine kinase 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT493845 | FOXN3 | forkhead box N3 | ![]() |
![]() |
2 | 4 | ||||||
MIRT494743 | ARHGAP1 | Rho GTPase activating protein 1 | ![]() |
![]() |
2 | 6 | ||||||
MIRT496491 | MAST3 | microtubule associated serine/threonine kinase 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT503312 | FICD | FIC domain containing | ![]() |
![]() |
2 | 4 | ||||||
MIRT503507 | ZNF623 | zinc finger protein 623 | ![]() |
![]() |
2 | 2 | ||||||
MIRT504182 | FAM127B | retrotransposon Gag like 8A | ![]() |
![]() |
2 | 2 | ||||||
MIRT505010 | ZNF644 | zinc finger protein 644 | ![]() |
![]() |
2 | 2 | ||||||
MIRT505352 | TMEM167A | transmembrane protein 167A | ![]() |
![]() |
2 | 2 | ||||||
MIRT505645 | SHOC2 | SHOC2, leucine rich repeat scaffold protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT505710 | SESN2 | sestrin 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT505777 | SATB2 | SATB homeobox 2 | ![]() |
![]() |
2 | 6 | ||||||
MIRT506208 | PHF19 | PHD finger protein 19 | ![]() |
![]() |
2 | 2 | ||||||
MIRT506251 | PEG10 | paternally expressed 10 | ![]() |
![]() |
2 | 2 | ||||||
MIRT507786 | CDKN1B | cyclin dependent kinase inhibitor 1B | ![]() |
![]() |
2 | 2 | ||||||
MIRT508005 | BCL2L13 | BCL2 like 13 | ![]() |
![]() |
2 | 4 | ||||||
MIRT508857 | ZRSR1 | zinc finger CCCH-type, RNA binding motif and serine/arginine rich 1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT510546 | XBP1P1 | X-box binding protein 1 pseudogene 1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT511892 | GAS1 | growth arrest specific 1 | ![]() |
![]() |
2 | 6 | ||||||
MIRT512907 | UBL4A | ubiquitin like 4A | ![]() |
![]() |
2 | 2 | ||||||
MIRT513600 | VPS37B | VPS37B, ESCRT-I subunit | ![]() |
![]() |
2 | 2 | ||||||
MIRT521241 | SAR1A | secretion associated Ras related GTPase 1A | ![]() |
![]() |
2 | 2 | ||||||
MIRT521321 | RRAGD | Ras related GTP binding D | ![]() |
![]() |
2 | 4 | ||||||
MIRT525281 | C18orf32 | chromosome 18 open reading frame 32 | ![]() |
![]() |
2 | 2 | ||||||
MIRT528650 | RWDD2A | RWD domain containing 2A | ![]() |
![]() |
2 | 4 | ||||||
MIRT535101 | PODXL | podocalyxin like | ![]() |
![]() |
2 | 2 | ||||||
MIRT547752 | KBTBD6 | kelch repeat and BTB domain containing 6 | ![]() |
![]() |
2 | 4 | ||||||
MIRT547865 | HSPA13 | heat shock protein family A (Hsp70) member 13 | ![]() |
![]() |
2 | 2 | ||||||
MIRT549170 | BMP3 | bone morphogenetic protein 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT550115 | SLC35G2 | solute carrier family 35 member G2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT556097 | MOAP1 | modulator of apoptosis 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT557172 | HOXA13 | homeobox A13 | ![]() |
![]() |
2 | 2 | ||||||
MIRT557422 | GXYLT2 | glucoside xylosyltransferase 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT557931 | FAM73A | mitoguardin 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT568804 | VPS37D | VPS37D, ESCRT-I subunit | ![]() |
![]() |
2 | 2 | ||||||
MIRT571326 | TPCN2 | two pore segment channel 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT572598 | PAPLN | papilin, proteoglycan like sulfated glycoprotein | ![]() |
![]() |
2 | 2 | ||||||
MIRT573437 | APOPT1 | apoptogenic 1, mitochondrial | ![]() |
![]() |
2 | 2 | ||||||
MIRT574092 | VASN | vasorin | ![]() |
![]() |
2 | 2 | ||||||
MIRT608688 | VAV3 | vav guanine nucleotide exchange factor 3 | ![]() |
![]() |
2 | 4 | ||||||
MIRT608800 | ITGA11 | integrin subunit alpha 11 | ![]() |
![]() |
2 | 4 | ||||||
MIRT610332 | SSX5 | SSX family member 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT613158 | DDA1 | DET1 and DDB1 associated 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT625407 | CPEB3 | cytoplasmic polyadenylation element binding protein 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT636603 | CLIC5 | chloride intracellular channel 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT638573 | IER5 | immediate early response 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT639686 | AASDHPPT | aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase | ![]() |
![]() |
2 | 2 | ||||||
MIRT677979 | ITGB3 | integrin subunit beta 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT685217 | POTED | POTE ankyrin domain family member D | ![]() |
![]() |
2 | 2 | ||||||
MIRT702570 | JARID2 | jumonji and AT-rich interaction domain containing 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT706259 | MKLN1 | muskelin 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT734675 | HMGB1 | high mobility group box 1 | ![]() |
![]() |
![]() |
3 | 0 | |||||
MIRT736369 | HSPA1A | heat shock protein family A (Hsp70) member 1A | ![]() |
1 | 0 |
miRNA-Drug Associations | |||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|